Komori
Tri Chemical Laboratories (4369) · FactHigher Cash Balance for the Interim Period

Increase in cash and cash equivalents

First written in FY2022-Q3. 5 of 17 entries say "Advanced", first in FY2022. Latest entry: FY2027-H1.

17entries
6years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2024-Q2 – FY20262021: 12022: 420222023: 420232024: 320242025: 220252026: 32026
Same theme, other companies
Changes in Cash HoldingsA theme 114 companies write about · 70 as a headwind · 63 as a tailwind

65 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 114 companies compared. The sentences above are computed from all 114.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Higher Cash Balance for the Interim PeriodAnnual report

    「Cash and cash equivalents at the end of the current interim consolidated accounting period, hereinafter referred to as “funds,” increased by ¥2,798,625 thousand from the end of the previous consolidated fiscal year to ¥10,078,603 thousand.」

    Cash and cash equivalents increased by ¥2,798,625 thousand from ¥7,279,978 thousand at the end of the previous fiscal year to ¥10,078,603 thousand. The interim-period balance shifted to an increase after declining through the previous fiscal year.
  2. 2026-08-31AdvancedEarnings

    「Increase (decrease) in cash and cash equivalents (△ indicates a decrease) △2,342,993 2,798,625」

    Cash and cash equivalents increased by ¥2,798,625 thousand during the interim period, supported by cash flows from operating activities and other factors.
  3. FY2026Decrease in the full-year cash balanceAnnual report

    「Cash and cash equivalents at the end of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥2,159,350 thousand from the end of the previous consolidated fiscal year to ¥7,279,978 thousand.」

    Cash and cash equivalents decreased from ¥9,439,328 thousand at the end of the previous fiscal year to ¥7,279,978 thousand. Investment spending on the Minami-Alps facility and other sites was the main source of cash outflow.
  4. FY2026-H1Decrease in the interim-period cash balanceAnnual report

    「Cash and cash equivalents at the end of the current interim consolidated accounting period, hereinafter referred to as “funds,” decreased by ¥2,342,993 thousand from the end of the previous consolidated fiscal year to ¥7,096,335 thousand.」

    Cash and cash equivalents decreased by ¥2,342,993 thousand from ¥9,439,328 thousand at the end of the previous consolidated fiscal year to ¥7,096,335 thousand.
  5. FY2025Decrease in the full-year cash balanceAnnual report

    「Cash and cash equivalents at the end of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥1,058,016 thousand from the end of the previous consolidated fiscal year to ¥9,439,328 thousand.」

    Cash and cash equivalents decreased from ¥10,497,345 thousand at the end of the previous fiscal year to ¥9,439,328 thousand.
  6. FY2025-H1Decrease in the interim-period cash balanceAnnual report

    「Cash and cash equivalents at the end of the current interim consolidated accounting period, hereinafter referred to as “funds,” decreased by ¥966,718 thousand from the end of the previous consolidated fiscal year to ¥9,530,627 thousand.」

    Cash and cash equivalents decreased by ¥966,718 thousand from ¥10,497,345 thousand at the end of the previous fiscal year to ¥9,530,627 thousand.
  7. FY2025-Q1Smaller increase in the first-quarter cash balanceAnnual report

    「Cash and cash equivalents at the end of the cumulative first quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” increased by ¥656,673 thousand from the end of the previous consolidated fiscal year to ¥11,154,019 thousand.」

    Cash and cash equivalents increased by ¥656,673 thousand from the end of the previous fiscal year, but the increase was smaller than the ¥1,250,081 thousand increase in the same period of the previous year.
  8. FY2024Decrease in the full-year cash balanceAnnual report

    「Cash and cash equivalents at the end of the current consolidated fiscal year, hereinafter referred to as “funds,” decreased by ¥640,454 thousand from the end of the previous consolidated fiscal year to ¥10,497,345 thousand.」

    Cash and cash equivalents decreased by ¥640,454 thousand from ¥11,137,800 thousand at the end of the previous fiscal year to ¥10,497,345 thousand.
  9. FY2024-Q3Smaller increase in the third-quarter cash balanceAnnual report

    「Cash and cash equivalents at the end of the cumulative third quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” increased by ¥249,776 thousand from the end of the previous consolidated fiscal year to ¥11,387,576 thousand.」

    Cash and cash equivalents increased by ¥249,776 thousand from the end of the previous fiscal year to ¥11,387,576 thousand, but the increase was smaller than the ¥2,891,425 thousand increase in the same period of the previous year.
  10. FY2024-Q2Smaller increase in the second-quarter cash balanceAnnual report

    「Cash and cash equivalents at the end of the cumulative second quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” increased by ¥1,107,581 thousand from the end of the previous consolidated fiscal year to ¥12,245,382 thousand.」

    Cash and cash equivalents increased by ¥1,107,581 thousand from the end of the previous consolidated fiscal year to ¥12,245,382 thousand. The increase was smaller than the ¥2,272,166 thousand increase in the same period of the previous year.
  11. FY2024-Q1AdvancedAnnual report

    「Cash and cash equivalents at the end of the cumulative first quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” increased by ¥1,250,081 thousand from the end of the previous consolidated fiscal year to ¥12,387,881 thousand.」

    Cash and cash equivalents increased by ¥1,250,081 thousand from the end of the previous fiscal year to ¥12,387,881 thousand.
  12. FY2023AdvancedAnnual report

    「Cash and cash equivalents at the end of the current consolidated fiscal year increased by ¥3,103,305 thousand from the end of the previous consolidated fiscal year to ¥11,137,800 thousand.」

    Cash and cash equivalents increased by ¥3,103,305 thousand from the end of the previous fiscal year to ¥11,137,800 thousand.
  13. FY2023-Q3Increase in the third-quarter cash balanceAnnual report

    「Cash and cash equivalents at the end of the cumulative third quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” increased by ¥2,891,425 thousand from the end of the previous consolidated fiscal year to ¥10,925,920 thousand.」

    Cash and cash equivalents increased by ¥2,891,425 thousand from the end of the previous consolidated fiscal year to ¥10,925,920 thousand.
  14. FY2023-Q2Smaller increase in the second-quarter cash balanceAnnual report

    「Cash and cash equivalents at the end of the cumulative second quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” increased by ¥2,272,166 thousand from the end of the previous consolidated fiscal year to ¥10,306,661 thousand.」

    Cash and cash equivalents increased by ¥2,272,166 thousand from the end of the previous consolidated fiscal year to ¥10,306,661 thousand. Although the balance decreased from the amount reported for the previous quarter, it continued to increase compared with the previous fiscal year-end.
  15. FY2023-Q1AdvancedAnnual report

    「Cash and cash equivalents at the end of the cumulative first quarter of the current consolidated fiscal year, hereinafter referred to as “funds,” increased by ¥2,577,902 thousand from the end of the previous consolidated fiscal year to ¥10,612,396 thousand.」

    Cash and cash equivalents increased by ¥2,577,902 thousand from the end of the previous consolidated fiscal year to ¥10,612,396 thousand.
  16. FY2022AdvancedAnnual report

    「Cash and cash equivalents at the end of the current consolidated fiscal year increased by ¥6,335,882 thousand from the end of the previous consolidated fiscal year to ¥8,034,494 thousand.」

    Cash and cash equivalents increased by ¥6,335,882 thousand from the end of the previous fiscal year to ¥8,034,494 thousand.
  17. FY2022-Q3First statedAnnual report

    「At the end of the cumulative third quarter consolidated period under review, cash and cash equivalents, hereinafter referred to as “funds,” had increased by ¥5,325,124 thousand from the end of the previous consolidated fiscal year to ¥7,023,736 thousand.」

    The disclosure reports a ¥5,325,124 thousand increase in cash and cash equivalents from the previous consolidated fiscal year-end, to ¥7,023,736 thousand.
Moved together

"Strengthening, Streamlining and Rebuilding the Production Structure" moved the same way as this thread, in the same document, in 4 of its 17 moves.

444442★123456
  1. ★This thread
  2. 1Strengthening, Streamlining and Rebuilding the Production Structure4×
  3. 2Dependence on Interest-Bearing Debt and Rising Interest Rates4×
  4. 3Reducing Dependence on Interest-Bearing Debt through Higher Profit4×
  5. 4Operating cash flow turns positive4×
  6. 5Increase in net assets4×
  7. 6Dividends funded by retained earnings2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Tri Chemical Laboratories yet. It last moved in the Earnings of 2026-08-31: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Increase in cash and cash equivalents | Tri Chemical Laboratories Inc. (4369) | Komori